PHARMACIE DE LA BASILIQUE : revenue, balance sheet and financial ratios

PHARMACIE DE LA BASILIQUE is a French company founded 22 years ago, specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé. Based in SAINT-MAXIMIN-LA-SAINTE-BAUME (83470), this company of category PME shows in 2023 a revenue of 6.6 M€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-04-25

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Financial history - PHARMACIE DE LA BASILIQUE (SIREN 452486400)
Indicator 2024 2023 2022 2021 2020 2019 2018
Revenue N/C 6 553 503 € 6 754 487 € 6 221 997 € 5 132 668 € 5 803 011 € 4 947 660 €
Net income 271 556 € 366 586 € 330 981 € 414 471 € 334 143 € 227 722 € 303 221 €
EBITDA N/C 561 243 € 501 169 € 555 171 € 222 992 € 369 571 € 366 201 €
Net margin N/C 5.6% 4.9% 6.7% 6.5% 3.9% 6.1%

Revenue and income statement

In 2024, PHARMACIE DE LA BASILIQUE generates positive net income of 272 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2018-2024: 303 k€ -> 272 k€.

Net income (2024) ?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax

271 556 €

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Solvency and debt ratios

The debt ratio (= Financial debt / Equity x 100) stands at 172%. Critical situation: debt significantly exceeds equity, severely limiting borrowing capacity and exposing the company to default risk. Financial autonomy (= Equity / Total assets x 100) reaches 32%. The balance between equity and debt is satisfactory.

Debt ratio (2024) ?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low
50-100% : Moderate
> 100% : High

171.574%

Financial autonomy (2024) ?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy
20-30% : Average
< 20% : Low

32.037%

Asset age ratio (2024) ?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Interpretation
< 50% : Recent assets
50-70% : Normal wear
> 70% : Aging assets

50.4%

Solvency indicators evolution
PHARMACIE DE LA BASILIQUE

Sector positioning

Debt ratio
171.57 2024
2022
2023
2024
Q1: 16.46
Med: 58.48
Q3: 154.77
Average

In 2024, the debt ratio of PHARMACIE DE LA BASILIQUE (171.57) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.

Financial autonomy
32.04% 2024
2022
2023
2024
Q1: 28.91%
Med: 49.95%
Q3: 69.47%
Average

In 2024, the financial autonomy of PHARMACIE DE LA BASILIQUE (32.0%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.

Repayment capacity
7.92 years 2023
2022
2023
Q1: 0.95 years
Med: 3.58 years
Q3: 7.48 years
Average

In 2023, the repayment capacity of PHARMACIE DE LA BASILIQUE (7.92) ranks above the median of the sector. This ratio indicates the number of years needed to repay debt with cash flow. A reduction effort could improve financial strength.

Liquidity ratios

The liquidity ratio (= Current assets / Current liabilities) stands at 109.04. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.

Liquidity ratio (2024) ?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good
1-1.5 : Fair
< 1 : Liquidity risk

109.036

Liquidity indicators evolution
PHARMACIE DE LA BASILIQUE

Sector positioning

Liquidity ratio
109.04 2024
2022
2023
2024
Q1: 129.46
Med: 182.14
Q3: 260.79
Watch -10 pts over 3 years

In 2024, the liquidity ratio of PHARMACIE DE LA BASILIQUE (109.04) ranks in the bottom 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio below 1 may signal potential cash flow tensions.

Interest coverage
2.88x 2023
2022
2023
Q1: 0.38x
Med: 2.71x
Q3: 6.47x
Good -12 pts over 2 years

In 2023, the interest coverage of PHARMACIE DE LA BASILIQUE (2.9x) ranks above the median of the sector. This ratio indicates how many times operating income covers interest expenses. This comfortable position offers an appreciable safety margin.

Working capital requirement (WCR) and payment terms

Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.

Operating WCR (2024) ?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released
Positive = financing needed

0 €

Customer credit (2024) ?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good
45-60j : Average
> 60j : Long

0 j

Supplier credit (2024) ?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow

0 j

Inventory turnover (2024) ?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover

0 j

WCR and payment terms evolution
PHARMACIE DE LA BASILIQUE

Positioning of PHARMACIE DE LA BASILIQUE in its sector

Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé

Valuation estimate

Based on 225 transactions of similar company sales in 2024, the value of PHARMACIE DE LA BASILIQUE is estimated at 3 791 122 € (range 2 640 077€ - 5 671 736€). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.

Estimated enterprise value 2024
225 transactions
2640k€ 3791k€ 5671k€
3 791 122 € Range: 2 640 077€ - 5 671 736€
NAF 5 année 2024

Valuation method used

Net Income Multiple
271 556 € × 14.0x = 3 791 123 €
Range: 2 640 078€ - 5 671 736€

Only this financial indicator is available for this company.

Valuation evolution

How is this estimate calculated?

This estimate is based on the analysis of 225 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.

  • EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
  • Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
  • Net Income Multiple: Relevant for mature companies with stable results.

This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).

Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)

Compare PHARMACIE DE LA BASILIQUE with other companies in the same sector:

Voir toutes les statistiques du secteur Commerce de détail de produits pharmaceutiques en magasin spécialisé

Frequently asked questions about PHARMACIE DE LA BASILIQUE

What is the revenue of PHARMACIE DE LA BASILIQUE ?

The revenue of PHARMACIE DE LA BASILIQUE in 2023 is 6.6 M€.

Is PHARMACIE DE LA BASILIQUE profitable?

Yes, PHARMACIE DE LA BASILIQUE generated a net profit of 272 k€ in 2024.

Where is the headquarters of PHARMACIE DE LA BASILIQUE ?

The headquarters of PHARMACIE DE LA BASILIQUE is located in SAINT-MAXIMIN-LA-SAINTE-BAUME (83470), in the department Var.

Where to find the tax return of PHARMACIE DE LA BASILIQUE ?

The tax return of PHARMACIE DE LA BASILIQUE is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does PHARMACIE DE LA BASILIQUE operate?

PHARMACIE DE LA BASILIQUE operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.